School of Medicine, Oregon Health and Science University, 3181 SW Sam Jackson Park Rd, Portland, OR, USA.
Department of Dermatology, Oregon Health and Science University, Portland, OR, USA.
Semin Arthritis Rheum. 2022 Oct;56:152041. doi: 10.1016/j.semarthrit.2022.152041. Epub 2022 Jun 3.
Shared decision making is a collaborative process where patients and clinicians work together to understand the patient's situation and to determine how best to address it. While shared decision making offers benefits for patients and clinicians, shared decision making use across the field of rheumatology has not been previously described.
To perform a scoping review of research on shared decision making in rheumatology METHODS: We analyzed literature on shared decision making in rheumatology from Ovid MEDLINE, PsycINFO, Sciverse Scopus, EBM Reviews, and PsycARTICLES.
Of 3191 articles screened, 63 studies were included for analysis. Shared decision making in rheumatology improves patient satisfaction and adherence to treatment plans. We identified 13 patient decision aids from the studies and discussed the process of evaluating patient decision aids and shared decision making outcomes. The most important factors for decision making were understanding benefits versus side effects, medication logistics, and cost. Decision making conversations are affected by age, race, socioeconomic status, gender, health literacy, and language proficiency. Barriers to shared decision making include time constraints and training.
Our review identified 63 studies of shared decision making in rheumatology, including 13 studies of patient decision aids. Future areas of research include identifying tools for shared decision making, understanding social and cultural factors, and improving equity in shared decision making practices. By improving shared decision making practices in rheumatology, we can strive to improve patient experience, satisfaction, trust, and enhance outcomes for all.
共同决策是一个协作的过程，患者和临床医生共同努力了解患者的情况，并确定如何最好地解决问题。虽然共同决策为患者和临床医生带来了益处，但在风湿病学领域，共同决策的使用尚未得到描述。
对风湿病学中的共同决策研究进行范围综述。
我们分析了 Ovid MEDLINE、PsycINFO、Sciverse Scopus、EBM Reviews 和 PsycARTICLES 中关于风湿病学中共同决策的文献。
在筛选出的 3191 篇文章中，有 63 篇研究被纳入分析。风湿病学中的共同决策可提高患者的满意度和治疗计划的依从性。我们从研究中确定了 13 种患者决策辅助工具，并讨论了评估患者决策辅助工具和共同决策结果的过程。决策的最重要因素是了解益处与副作用、药物物流和成本。决策对话受到年龄、种族、社会经济地位、性别、健康素养和语言能力的影响。共同决策的障碍包括时间限制和培训。
我们的综述确定了 63 项关于风湿病学中共同决策的研究，包括 13 项关于患者决策辅助工具的研究。未来的研究领域包括确定共同决策的工具、了解社会和文化因素以及改善共同决策实践中的公平性。通过改善风湿病学中的共同决策实践，我们可以努力改善患者体验、满意度、信任，并改善所有人的结果。
